ibandronate

(redirected from Boniva)
Also found in: Medical, Wikipedia.
Related to Boniva: Boniva Injection
Translations

ibandronate, ibandronate sodium

(USAN), ibandronic acid (INN) n ibandronato, ibandronato sódico, ácido ibandrónico (INN)
References in periodicals archive ?
However, since drug makers later developed more convenient dose, Boniva has not appeared in the American market until the FDA approved its monthly use in 2005.
SM: The latest study by Merck, the company that makes Boniva, found that after seven years of taking a medication with bisphosphonates, like Boniva, the risk of fracture increases.
Its major drugs include Accutane for acne vulgaris, Aurorix for depression, Actemra for rheumatoid arthrritis, Boniva for osteopososis, Cellcept for transplant rejection and Dilatrend for hypertension.
In the lower-risk patients without a prior fracture, "that is where Boniva does not seem to work very well" in comparison with switching to another oral bisphosphonate.
This forecast assesses the impact of generics, especially upon patent expiry of key bisphosphonate drugs such as Actonel, Boniva, and Reclast.
Most of them are looking for solutions other than bisphosphonates like Fosamax, Actonel, and Boniva.
But bisphosphonates -- such as Merck's Fosamax, Roche's Boniva, Novartis's Reclast, and Warner Chilcott's Actonel -- remain the most popular option, and can be bought for as little as $10 per month in the US.
review, published in The New England Journal of Medicine online recently, was prompted by a growing debate over how long women should continue using the drugs, known as bisphosphonates, which are sold as generic versions of brands like Fosamax and Boniva, as well as Novartis's Reclast.
Jan Towers, AANP Director of Health Policy, "Contact your local legislator, every time you take your Boniva.
The NWHN will use all the advocacy tools at its disposal to press the FDA to make changes in how drug companies are allowed to market bisphosphonates like Fosamax, Actonel, Boniva and Reclast (as well as the many generic bisphosphonates) to healthy women.
Health urgings for bone mass density testing and drug advertising for Boniva are usually aimed at menopause-age women and older, making us view osteoporosis as a problem for mature women.
The FDA said the labels and medication guides will be changed to show the new warning in oral bisphosphonates including Actonel, Atelvia, Boniva, and Fosamax and injectable drugs including Boniva and Reclast, and their generic equivalents.